We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of the Digestive and Metabolic Utilisation of Dietary Protein in Patients With Chronic Pancreatitis

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00957151
First Posted: August 12, 2009
Last Update Posted: August 12, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Solvay Pharmaceuticals
Information provided by:
Hospital Avicenne
August 11, 2009
August 12, 2009
August 12, 2009
April 2004
August 2005   (Final data collection date for primary outcome measure)
To measure digestive and metabolic assimilation of dietary proteins in patients with chronic pancreatitis
Same as current
No Changes Posted
To determine the efficacy of enzyme therapy
Same as current
Not Provided
Not Provided
 
Evaluation of the Digestive and Metabolic Utilisation of Dietary Protein in Patients With Chronic Pancreatitis
Evaluation of the Digestive and Metabolic Utilisation of Dietary Protein in Patients With Chronic Pancreatitis
The objective is to evaluate the dietary nitrogen assimilation and metabolic utilisation capability of patients with chronic pancreatitis.
Not Provided
Interventional
Phase 4
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Chronic Pancreatitis
Drug: Creon
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
12
August 2005
August 2005   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • subjects with chronic pancreatitis and taking enzyme replacement therapy

Exclusion Criteria:

  • patients with hepatic impairment
  • patients allergic to dairy proteins
  • urinary incontinence affecting the measurement of nitrogen metabolism
  • digestive disorder affecting the absorption of nutrients
Sexes Eligible for Study: All
18 Years to 65 Years   (Adult)
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT00957151
04007
Not Provided
Not Provided
Not Provided
Pr Benamouzig Robert, AP-HP
Hospital Avicenne
Solvay Pharmaceuticals
Principal Investigator: Robert Benamouzig, Pr Department of Gastroenterology
Hospital Avicenne
August 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP